Royal Bank Of Canada Mannkind Corp Transaction History

Royal Bank Of Canada

$528 Billion
Q2 2025

A detailed history of Royal Bank Of Canada transactions in Mannkind Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 1,042,663 shares of MNKD stock, worth $4.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,042,663

Previous 209,178 398.46%

Holding current value

$4.79 Million

Previous $1.05 Million 270.63%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.71 - $5.04 $3.09 Million - $4.2 Million	833,485 Added 398.46%	1,042,663 $3.9 Million
Q1 2025 May 15, 2025	SELL	$4.92 - $6.6 $237,734 - $318,912	-48,320 Reduced 18.77%	209,178 $1.05 Million
Q4 2024 Feb 14, 2025	SELL	$5.93 - $7.44 $266,428 - $334,271	-44,929 Reduced 14.86%	257,498 $1.66 Million
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $729,135 - $975,091	145,536 Added 92.76%	302,427 $1.9 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $176,256 - $236,313	43,520 Added 38.39%	156,891 $818,000
Q1 2024 Nov 05, 2024	SELL	$3.25 - $5.27 $141,440 - $229,350	-43,520 Reduced 27.74%	113,371 $513,000
Q1 2024 May 15, 2024	SELL	$3.25 - $5.27 $237,734 - $385,495	-73,149 Reduced 39.22%	113,371 $513,000
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $175,650 - $225,611	52,590 Added 39.27%	186,520 $678,000
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.45 $692,941 - $965,865	-177,223 Reduced 56.96%	133,930 $553,000
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $42,225 - $54,371	-11,351 Reduced 3.52%	311,153 $1.27 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $451,437 - $643,441	114,288 Added 54.89%	322,504 $1.32 Million
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $116,354 - $206,895	38,528 Added 22.71%	208,216 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $58,783 - $85,521	19,660 Added 13.1%	169,688 $524,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $28,755 - $51,372	-10,770 Reduced 6.7%	150,028 $571,000
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $497,116 - $844,338	-189,739 Reduced 54.13%	160,798 $591,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $878,611 - $1.16 Million	216,941 Added 162.39%	350,537 $1.53 Million
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $68,518 - $96,524	17,614 Added 15.19%	133,596 $580,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $418,695 - $632,101	115,982 New	115,982 $633,000

Others Institutions Holding MNKD

# of Institutions

249

Shares Held

161M

Call Options Held

1.24M

Put Options Held

183K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.18B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Mannkind Corp Transaction History